• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型口服活性抗过敏药物DS-4574在实验性过敏和炎症模型中的作用

Effects of DS-4574, a new orally active antiallergic agent, in experimental allergic and inflammatory models.

作者信息

Aibara S, Mori M, Iwamoto T, Tsubokawa M, Takamori H, Tsukada W

机构信息

Exploratory Research Laboratories III, Daiichi Pharmaceutical Co., Ltd., Tokyo, Japan.

出版信息

Jpn J Pharmacol. 1993 Apr;61(4):267-76. doi: 10.1254/jjp.61.267.

DOI:10.1254/jjp.61.267
PMID:8320873
Abstract

The anti-allergic and anti-inflammatory activities of DS-4574, which possesses leukotriene antagonism and inhibits the release of immunologically stimulated mediators such as histamine and leukotrienes, were evaluated in several animal models. DS-4574 had dose-dependent inhibitory effects on IgE-mediated passive cutaneous anaphylaxis and the passive Arthus reaction in rats and the phase I response of Forssman antibody-induced bronchoconstriction. In contrast, this compound had no effect on the phase II response of Forssman antibody-induced bronchoconstriction in guinea pigs, the reverse cutaneous anaphylaxis in rats, complement-dependent hemolysis of sheep erythrocytes and the delayed-type hypersensitivity induced by methylated bovine serum albumin in mice. The results obtained in a double sensitization with two IgE antibodies suggested that DS-4574, as well as disodium cromoglycate, did not impair antigen-antibody combination but prevents the release of chemical mediators such as histamine. DS-4574 also had a weak inhibitory activity on carrageenin paw edema in rats, arachidonic acid ear edema in mice and adjuvant arthritis in rats. In addition, this compound inhibited increased vascular permeability in rat skin induced by leukotriene D4 and platelet activating factor-induced pleurisy in rats in a dose-dependent manner. These results indicate that DS-4574 inhibited type III allergic reactions and some inflammatory reactions. Therefore, DS-4574 could be useful in the treatment of allergic diseases such as asthma.

摘要

DS - 4574具有白三烯拮抗作用,并能抑制免疫刺激介质如组胺和白三烯的释放,其抗过敏和抗炎活性在多种动物模型中进行了评估。DS - 4574对大鼠IgE介导的被动皮肤过敏反应、被动Arthus反应以及福斯曼抗体诱导的支气管收缩的I期反应具有剂量依赖性抑制作用。相比之下,该化合物对豚鼠福斯曼抗体诱导的支气管收缩的II期反应、大鼠反向皮肤过敏反应、绵羊红细胞的补体依赖性溶血以及小鼠甲基化牛血清白蛋白诱导的迟发型超敏反应均无影响。用两种IgE抗体进行双重致敏实验所得结果表明,DS - 4574与色甘酸二钠一样,不会损害抗原 - 抗体结合,但可阻止组胺等化学介质的释放。DS - 4574对大鼠角叉菜胶性足肿胀、小鼠花生四烯酸耳肿胀以及大鼠佐剂性关节炎也具有微弱的抑制活性。此外,该化合物以剂量依赖性方式抑制白三烯D4诱导的大鼠皮肤血管通透性增加和血小板活化因子诱导的大鼠胸膜炎。这些结果表明,DS - 4574可抑制III型过敏反应和一些炎症反应。因此,DS - 4574可能对治疗哮喘等过敏性疾病有用。

相似文献

1
Effects of DS-4574, a new orally active antiallergic agent, in experimental allergic and inflammatory models.新型口服活性抗过敏药物DS-4574在实验性过敏和炎症模型中的作用
Jpn J Pharmacol. 1993 Apr;61(4):267-76. doi: 10.1254/jjp.61.267.
2
Antiallergic activity of 6-(2-cyclohexylethyl)-[1,3,4]thiadiazolo- [3,2-a]-1,2,3-triazolo-[4,5-d]pyrimidin-9(3H)-one (DS-4574) in rats.6-(2-环己基乙基)-[1,3,4]噻二唑并-[3,2-a]-1,2,3-三唑并-[4,5-d]嘧啶-9(3H)-酮(DS-4574)在大鼠体内的抗过敏活性
Int Arch Allergy Immunol. 1992;98(2):146-52. doi: 10.1159/000236178.
3
[[Effect of traxanox sodium on type I-IV allergic reactions. Studies on anti-allergic agents VII].[曲克芦丁钠对I - IV型过敏反应的影响。抗过敏药物研究VII]
Nihon Yakurigaku Zasshi. 1982 Dec;80(6):417-27.
4
Effects of FR50948, a new orally active antiallergic agent, in experimental allergic models.新型口服活性抗过敏剂FR50948在实验性过敏模型中的作用
Jpn J Pharmacol. 1988 Apr;46(4):337-48. doi: 10.1254/jjp.46.337.
5
Immunopharmacological actions of the new antiallergic drug butyl 3'-(1H-tetrazol-5-yl)oxanilate. 1st communication: effects on type I to type IV allergic reactions in animal models.新型抗过敏药物3'-(1H-四氮唑-5-基)氧代苯甲酸丁酯的免疫药理作用。第一篇通讯:对动物模型中I型至IV型过敏反应的影响。
Arzneimittelforschung. 1988 Jan;38(1):70-4.
6
Effects of quinotolast, a new orally active antiallergic drug, on experimental allergic models.新型口服活性抗过敏药物喹诺司特对实验性过敏模型的影响。
Jpn J Pharmacol. 1993 Sep;63(1):73-81. doi: 10.1254/jjp.63.73.
7
Inhibitory effect of HSR-6071, a new anti-allergic agent, on experimental asthma in rats and guinea-pigs.新型抗过敏药物HSR-6071对大鼠和豚鼠实验性哮喘的抑制作用
J Pharm Pharmacol. 1990 Apr;42(4):236-41. doi: 10.1111/j.2042-7158.1990.tb05399.x.
8
Anti-inflammatory properties of zinc protoporphyrin disodium (Zn-PP-2Na).
Agents Actions. 1992 Nov;37(3-4):273-83. doi: 10.1007/BF02028120.
9
Anti-allergic effects of ketanserin on animal models of allergic reactions.酮色林对过敏反应动物模型的抗过敏作用。
Arch Int Pharmacodyn Ther. 1990 Sep-Oct;307:172-82.
10
Pharmacological properties of YM-11124, a selective immunosuppressive agent for cell-mediated immunity.YM-11124的药理特性,一种针对细胞介导免疫的选择性免疫抑制剂。
Pharmacology. 1989;39(1):28-38. doi: 10.1159/000138568.

引用本文的文献

1
Antisecretory effect of DS-4574, a mast cell stabilizer with peptidoleukotriene antagonism, on gastric acid secretion in the pig.DS-4574(一种兼具肽白三烯拮抗作用的肥大细胞稳定剂)对猪胃酸分泌的抗分泌作用。
Agents Actions. 1994 Mar;41(1-2):17-20. doi: 10.1007/BF01986387.